Lataa...
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
Nucleotide-binding oligomerization domain leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome is pivotal in maintaining intestinal homeostasis and sustaining enteric immune responses in the setting of inflammatory bowel diseases. Drugs acting as NLRP3 blockers could repres...
Tallennettuna:
| Julkaisussa: | Front Pharmacol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6287041/ https://ncbi.nlm.nih.gov/pubmed/30559669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01405 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|